COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study.

MLA

Sancilio, Amelia, et al. “COVID-19 Symptom Severity Predicts Neutralizing Antibody Activity in a Community-Based Serological Study.” Scientific Reports, vol. 12, no. 1, July 2022, p. 12269. EBSCOhost, https://doi.org/10.1038/s41598-022-15791-6.

APA

Sancilio, A., Schrock, J. M., Demonbreun, A. R., D’Aquila, R. T., Mustanski, B., Vaught, L. A., Reiser, N. L., Velez, M. P., Hsieh, R. R., Ryan, D. T., Saber, R., McNally, E. M., & McDade, T. W. (2022). COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study. Scientific Reports, 12(1), 12269. https://doi.org/10.1038/s41598-022-15791-6

Chicago

Sancilio, Amelia, Joshua M Schrock, Alexis R Demonbreun, Richard T D’Aquila, Brian Mustanski, Lauren A Vaught, Nina L Reiser, et al. 2022. “COVID-19 Symptom Severity Predicts Neutralizing Antibody Activity in a Community-Based Serological Study.” Scientific Reports 12 (1): 12269. doi:10.1038/s41598-022-15791-6.